Episurf Medical AB (publ) Total Assets
Episurf Medical AB (publ) total assets. Based on the latest financial reports, Episurf Medical AB (publ) (EPIS-B) holds total assets worth Skr59.80 Million SEK (≈ $6.44 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Episurf Medical AB (publ) for the company's overall valuation and market capitalisation.
Total Assets of Episurf Medical AB (publ) (2009–2025)
Total assets of Episurf Medical AB (publ) from 2009 to 2025. This chart illustrates how Episurf Medical AB (publ)'s total assets have evolved over time, based on quarterly financial data. See Episurf Medical AB (publ) (EPIS-B) share price today for real-time trading data and today's change.
Episurf Medical AB (publ) - Asset Composition Analysis
Episurf Medical AB (publ) Total Assets Breakdown (December 2025)
Episurf Medical AB (publ) total assets breakdown as of December 2025. Episurf Medical AB (publ)'s total assets of Skr59.80 Million consist of 29.6% current assets and 70.4% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 11.9% |
| Accounts Receivable | Skr5.50 Million | 9.2% |
| Inventory | Skr3.00 Million | 5.0% |
| Property, Plant & Equipment | Skr5.10 Million | 8.5% |
| Intangible Assets | Skr37.10 Million | 62.0% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2009–2025)
This chart illustrates how Episurf Medical AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore EPIS-B working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Episurf Medical AB (publ)'s current assets represent 29.6% of total assets in 2025, a decrease from 40.3% in 2009.
- Cash Position: Cash and equivalents constituted 11.9% of total assets in 2025, down from 24.5% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 15.0% in 2009.
- Asset Diversification: The largest asset category is intangible assets at 62.0% of total assets.
Episurf Medical AB (publ) Competitors by Total Assets
Key competitors of Episurf Medical AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Episurf Medical AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 4.29 | 10.95 |
| Quick Ratio | 1.41 | 4.06 | 10.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr7.30 Million | Skr45.80 Million | Skr130.30 Million |
Episurf Medical AB (publ) - Advanced Valuation Insights
This section examines the relationship between Episurf Medical AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.36 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | -38.9% |
| Total Assets | Skr59.80 Million |
| Market Capitalization | $10.32 Million USD |
Valuation Analysis
Below Book Valuation: The market values Episurf Medical AB (publ)'s assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Episurf Medical AB (publ)'s assets decreased by 38.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Episurf Medical AB (publ) (2009–2025)
The table below shows the annual total assets of Episurf Medical AB (publ) from 2009 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr59.80 Million ≈ $6.44 Million |
-38.85% |
| 2024-12-31 | Skr97.80 Million ≈ $10.52 Million |
-6.23% |
| 2023-12-31 | Skr104.30 Million ≈ $11.22 Million |
-47.11% |
| 2022-12-31 | Skr197.20 Million ≈ $21.22 Million |
-27.12% |
| 2021-12-31 | Skr270.60 Million ≈ $29.12 Million |
+45.95% |
| 2020-12-31 | Skr185.40 Million ≈ $19.95 Million |
+221.88% |
| 2019-12-31 | Skr57.60 Million ≈ $6.20 Million |
+5.11% |
| 2018-12-31 | Skr54.80 Million ≈ $5.90 Million |
-41.26% |
| 2017-12-31 | Skr93.29 Million ≈ $10.04 Million |
+54.69% |
| 2016-12-31 | Skr60.30 Million ≈ $6.49 Million |
-48.98% |
| 2015-12-31 | Skr118.20 Million ≈ $12.72 Million |
+173.37% |
| 2014-12-31 | Skr43.24 Million ≈ $4.65 Million |
-43.42% |
| 2013-12-31 | Skr76.42 Million ≈ $8.22 Million |
+173.80% |
| 2012-12-31 | Skr27.91 Million ≈ $3.00 Million |
-44.78% |
| 2011-12-31 | Skr50.55 Million ≈ $5.44 Million |
+348.38% |
| 2010-12-31 | Skr11.27 Million ≈ $1.21 Million |
+835.53% |
| 2009-12-31 | Skr1.20 Million ≈ $129.67K |
-- |
About Episurf Medical AB (publ)
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more